Dana Investment Advisors’s TG Therapeutics TGTX Stock Holding History

Dana Investment Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Sell	42,012 -1,942	-4%	-$79.5K	0.06%	310
2026 Q1	$1.46M	Buy	43,954 +1,877	+4%	+$55.9K	0.04%	358
2025 Q4	$1.25M	Buy	42,077 +6,419	+18%	+$210K	0.04%	374
2025 Q3	$1.29M	Buy	35,658 +7,361	+26%	+$242K	0.04%	359
2025 Q2	$1.02M	Sell	28,297 -1,784	-6%	-$66.4K	0.03%	385
2025 Q1	$1.19M	Sell	30,081 -7,569	-20%	-$255K	0.04%	357
2024 Q4	$1.13M	Buy	37,650 +215	+0.6%	+$6.17K	0.04%	366
2024 Q3	$876K	Sell	37,435 -248	-0.7%	-$5.42K	0.03%	397
2024 Q2	$670K	Sell	37,683 -212	-0.6%	-$3.38K	0.02%	413
2024 Q1	$576K	Buy	37,895 +17,141	+83%	+$273K	0.02%	426
2023 Q4	$354K	Sell	20,754 -36,805	-64%	-$428K	0.02%	360
2023 Q3	$481K	Buy	57,559 +20,932	+57%	+$292K	0.02%	317
2023 Q2	$910K	Sell	36,627 -2,593	-7%	-$67K	0.04%	242
2023 Q1	$590K	Buy	+39,220	New	+$596K	0.03%	293

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Dana Investment Advisors's TGTX Position: Q2 2026 in Review

Dana Investment Advisors reduced its TG Therapeutics (TGTX) stake by 4.4% in Q2 2026, selling an estimated $79.5K and leaving 42,012 shares worth $2.31M. The position accounts for 0.06% of the portfolio, ranked #310.

Dana Investment Advisors first reported a position in TGTX in Q1 2023 and has held it in 14 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Dana Investment Advisors held 42,012 shares of TG Therapeutics worth $2.31M as of Q2 2026.
Dana Investment Advisors sold 1,942 TG Therapeutics shares in Q2 2026, an estimated $79.5K.
TG Therapeutics made up 0.06% of Dana Investment Advisors's portfolio in Q2 2026, its #310 holding.
Dana Investment Advisors first reported a position in TG Therapeutics in Q1 2023 and has held it in 14 quarters since.
428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.